# Wenzel Spine, Inc.: Form D filings

Wenzel Spine, Inc., a biotechnology company in Austin, TX, filed 4 Form D notices with the SEC between 2009 and 2021. The latest, on November 10, 2021, reports $500,000 sold of a $1.5 million offering to 1 investor.

Find out what Wenzel Spine, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Wenzel%20Spine%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Wenzel%20Spine%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fwenzel-spine-inc-1475847)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Wenzel%20Spine%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Wenzel%20Spine%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fwenzel-spine-inc-1475847)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1130 RUTHERFORD LANE, SUITE 200, Austin, TX, 78753
- Phone: (512) 469-0600
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1475847

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 10, 2021 | New notice | $1,500,000 | $500,000 | $1,000,000 | 1 | Nov 3, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1475847/000147584721000002/0001475847-21-000002-index.htm) |
| Jan 30, 2019 | New notice | $3,499,789 | $1,000,000 | $2,499,789 | 1 | Jan 11, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1475847/000147584719000002/0001475847-19-000002-index.htm) |
| Jan 19, 2017 | New notice | $3,000,000 | $1,600,000 | $1,400,000 | 8 | Jan 17, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1475847/000147584717000001/0001475847-17-000001-index.htm) |
| Nov 16, 2009 | New notice | $2,500,000 | $1,800,000 | $700,000 | 6 | Oct 29, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1475847/000147584709000002/0001475847-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Warren Neely | Director |  |
| Phillip Hodges | Director |  |
| William Wilson | Executive Officer |  |
| Philip Sanger | Director |  |
| Chad Neely | Executive Officer, Director |  |
| Anthony Lacenere | Director |  |

## Other biotechnology companies in Texas that filed recently

- [Nuclein, LLC](https://specstream.ai/data/form-d/company/nuclein-llc-1787352) $15.7 million · Oct 27, 2026
- [OncoNano Medicine, Inc.](https://specstream.ai/data/form-d/company/onconano-medicine-inc-1735726) $10.1 million · Oct 8, 2026
- [Solaris Endovascular Inc.](https://specstream.ai/data/form-d/company/solaris-endovascular-inc-2156481) $5 million · Oct 1, 2026
- [Hera Biotech, Inc.](https://specstream.ai/data/form-d/company/hera-biotech-inc-1831293) $1.7 million · Sep 23, 2026
- [Kayak Therapeutics, Inc.](https://specstream.ai/data/form-d/company/kayak-therapeutics-inc-2088831) $25 million · Aug 21, 2026
- [InnovoTEX Inc.](https://specstream.ai/data/form-d/company/innovotex-inc-1971887) $2.7 million · Aug 18, 2026

[Every Form D from the week of Nov 8, 2021](https://specstream.ai/data/form-d/week/2021-11-08) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Wenzel Spine, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).